Disc Medicine Presents Initial Results from RESTORE-PV Phase 2 Trial in Patients with Polycythemia Vera (PV) at the 14th Society of Hematologic Oncology Annual Meeting
Disc Medicine, Inc. presented positive initial results from the RESTORE-PV Phase 2 trial of DISC-3405 in patients with polycythemia vera. The data, presented in a poster session at the 2026 Society... presented positive initial results from the RESTORE-PV Phase 2 trial of DISC…